Corine K.M. Buitenhuis

A comparison of targetting of neuroblastoma with mIBG and anti L1-CAM antibody mAb chCE7: therapeutic efficacy in a neuroblastoma xenograft model and imaging of neuroblastoma patients

Cornelis A. Hoefnagel, Marja Rutgers, Corine K.M. Buitenhuis et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2001 · 55 citations

Medicine, Cancer Biology, Oncology +9

Pharmacokinetics and intracellular distribution of the tumor‐targeted radiopharmaceutical <i>m</i>‐iodo‐benzylguanidine in SK‐N‐SH neuroblastoma and PC‐12 pheochromocytoma cells

Lou A. Smets, Manon Janssen, Marja Rutgers et al. · International Journal of Cancer · 1991 · 43 citations

Medicine, Pharmacokinetics, Pharmacology +13

Targeting of meta-iodobenzylguanidine to SK-N-SH human neuroblastoma xenografts: Tissue distribution, metabolism and therapeutic efficacy

Marja Rutgers, Corine K.M. Buitenhuis, C.A. Hoefnagel et al. · International Journal of Cancer · 2000 · 24 citations

Medicine, Oncology, Pharmacokinetics +17

[131I]- and [125I]metaiodobenzylguanidine therapy in macroscopic and microscopic tumors:A comparative study in SK-N-SH human neuroblastoma and PC12 rat pheochromocytoma xenografts

Marja Rutgers, Corine K.M. Buitenhuis, Martin A. van der Valk et al. · International Journal of Cancer · 2000 · 22 citations · Full text

Medicine, Nuclear Medicine, Pharmacology +13

Selective serotonin reuptake inhibitors (SSRIs) prevent meta-iodobenzylguanidine (MIBG) uptake in platelets without affecting neuroblastoma tumor uptake

Thomas Blom, Rutger Meinsma, Marja Rutgers et al. · EJNMMI Research · 2020 · 14 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14